Identification, sequencing and serology of HLA-B*3527

Tissue Antigens

Volumn 53, Issue 4 I, 1999, Pages 383-385

  Guttridge, M G ^a   Thompson, J ^a   Street, J ^a   Darke, C ^a  

^a Welsh Blood Service   (United Kingdom)

Author keywords

HLA B*35 alleles; HLA B35 specificity

Indexed keywords

ASPARAGINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; SERINE;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; FAMILY STUDY; GENE FREQUENCY; HAPLOTYPE; HUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROLOGY; UNITED KINGDOM;

ALLELES; BASE SEQUENCE; GENE FREQUENCY; GREAT BRITAIN; HLA-B ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 0032754565     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530411.x     Document Type: Article

References (15)

1. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1996. Tissue Antigens 1997: 49: 297-321.
2. Albert ED, Mickey MR, Terasaki PI. Serology and the genetics of Te58 (w18) and other specificities included in the 4c complex. Tissue Antigens 1972: 1: 47-56.
3. Engelfriet CP, Veenhoven von Riesz E, Kort-Bakker M, van der Berg-Loonen PM. Some studies with anti-4C, anti-R, anti-HL-A5, anti-W5, W18 and description of a new antigen in the FOUR segregant series, called H.R. In: Dausset J, Colombani J, eds. Histocompatibility Testing 1972. Munksgaard: Copenhagen, 1973: 475-8.
4. Tait BD, Hammond M, Stavropoulos-Giokas C et al. ATIS (4;B5, B35, B53, B18, B5102, B5103, B78. In: Charron D, ed. Genetic diversity of HLA. Function and Medical Implications, Vol 1. Paris: EDK, 1997: 47-55.
5. Wan AM, Ennis P, Parham P, Holmes N. The primary structure of HLA-A32 suggests a region involved in the formation of the Bw4/Bw6 epitopes. J Immunol 1986: 137: 3671-4.
6. Darke C, Guttridge MG, Thompson J et al. HLA-class I (A,B) and II (DR,DQ) gene and haplotype frequencies in blood donors from Wales, Exp Clin Immunogenet 1998: 15: 69-83.
7. Sims E, Cross SJ. Phenotyping of human complement component C4, a class III HLA antigen. Biochem J 1986: 239: 763-7.
8. Awdeh ZL, Alper CA. Inherited structural polymorphism of the forth component of human complement (C4), Proc Natl Acad Sci U S A 1980: 77: 3576-80.
9. Alper CA. Inherited structural polymorphism in human C2: evidence for genetic linkage between C2 and Bf. J Exp Med 1976: 144: 1111-5.
10. Abbal M, Thomsen M, Cambon-Thomsen A, Archambeau J, Calot M, Fathallah D. Two subtypes of BfF by isoelectric focusing: differential linkage to other HLA markers. Human Genetics 1985: 69: 181-3.
11. Rees MT, McGregor M, Guttridge MG et al. Current status of the Welsh Bone Marrow Donor Registry volunteer panel HLA typing quality, demography, CMV status, attrition. Eur J Immunogenet 1998: 25: 69.
12. Cereb N, Maye P, Lee S, Kong Y, Yang SY. Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B and -C alleles. Tissue Antigens 1995: 45: 1-11.
13. Cereb N, Yang SY. Dimorphic primers derived from intron 1 for use in the molecular typing of HLA-B alleles. Tissue Antigens 1997: 50: 74-6.
14. Pera C, Delfino L, Morabito A et al. HLA-A typing: comparison between serology, the amplification refractory mutation system with polymerase chain reaction and sequencing. Tissue Antigens 1997: 50: 372-9.
15. Johnston-Dow L, Versluis L, Chadwick R, Parham P, Tilanus M, Kronick M. A general approach for sequencing based typing of HLA-A. Hum Immunol 1995: 44 (Suppl 1): 160.